DatasetName,NCAPH2_S(208) NCAPH2_S(232) NCAPH2_S(240) NCAPH2_S(246) NCAPH2_S(250) NCAPH2_S(251) NCAPH2_S(260) NCAPH2_S(282) NCAPH2_S(283) NCAPH2_S(284) NCAPH2_S(286) NCAPH2_S(288) NCAPH2_S(308) NCAPH2_S(470) NCAPH2_S(482) NCAPH2_S(95),NCAPH2_S(175) NCAPH2_S(200) NCAPH2_S(25) NCAPH2_S(262) NCAPH2_S(466) NCAPH2_S(492)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5460792843382968,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5554785844363579,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.560407617435132,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5619678031261918,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5586008689249355,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5378009223457196,0.41869882826151494
WZ2023_Pu_010_30min,0.5571144217502382,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5519869379386645,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.561312296101633,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5606870261122958,0.38682148220766593
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5508374422509218,
AH2018_SILAC_MR_2_N,,0.41484588065561584
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5504076326361378,0.4178302647374507
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5602649403796852,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5680544607418712,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5583884154004978,
KBE2022_Log2_Ex_34_U,0.5609943093236801,
WZ2023_Pu_005_10min,0.5661809864974795,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.552218034821081,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5636934160676819,
AH2018_SILAC_MR_2_X,,0.44742101391870964
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.564878569714656,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5661958640589556,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5601464546664129,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.56603813094738,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.5613584230358503,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5639436461092086,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5654154564458332,
CK2022_11 40-1,0.5528111675204803,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5658325770061237,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.554844213813051,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5557724155816285,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5607656481758462,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5626470314041824,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5500251578864952,
CK2022_1 200-1,0.5613880945113451,
PG2020_Intensity Mock_10h_D,,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5835162060952459,0.4327583359771099
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5629093065000148,
PG2020_Intensity 2h_C,0.5463217747321364,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5578586156295073,
KBE2022_Log2_Ex_8_T,0.5608741118465213,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5564289969261439,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.569888277725642,
CK2022_3 40-1,0.5552361176467353,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5520688288737067,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5620462662198082,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5600353349006169,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.558816428056672,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,
CF2017_EOC 3,,0.4181303960170961
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5656991026974874,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5544930400640292,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5477762780655362,
KS2014_Intensity N3,0.5713329825632437,0.4384227805553595
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5570663198108967,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5721519949916727,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5540369452867495,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5525470199701653,0.42318728629057656
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5602155714178152,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5589961927253374,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5605410639861333,0.4168768629426975
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.5582735152315091,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5406091617698098,0.42061912762935183
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5582785693610214,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5628295032442167,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5541521742529008,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5560385134279393,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5517753098024506,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5623939518281571,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5631327458108142,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5617105922669444,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5546967570711643,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5620437400237267,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5534107763078996,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5653611032026081,
CK2022_11 200-1,0.5620488421283452,
CK2022_12 200-1,0.5624416498316841,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5562880156264669,
WZ2023_Su_010_20min,0.5531850887402975,
AH2018_TMTMS2_2_N,0.5595766167595483,0.3875888389069053
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5644746451767747,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5625851363776971,
KS2014_Intensity N4,0.5735811048405011,0.42445300368010136
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.4065614722832826
CK2022_14 200-1,0.5636218428202745,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5620635157433127,
AST2020_anti-CD3+PDL2.2,0.5585415141277107,
PG2020_Intensity Mock_10h_A,0.5555814666007084,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5514611630717703,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5653608950710602,
CF2017_EOC 1,,0.3842634591763325
CK2022_3 200-1,0.5615819909410018,
AH2018_LFQ_IT_3_C,0.5647384794159669,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5541443874602757,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5616851480909304,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5485208530194103,
AR2021_ALG 1 μM,0.5538178785029001,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5535101748672229,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,0.5453444938785172,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5632073793214206,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5511912472102221,
CK2022_16 16-1,0.5509524550481013,
FS2019_db/db3,,
CK2022_15 40-1,0.5552865626640537,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5577057233512224,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5628835186928752,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5657881982851007,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5571683014289728,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5641007719854615,
AH2018_LFQ_M_1_N,0.5619475303481531,
KBE2022_Log2_Ex_27_U,0.5577738299341202,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.557383143118812,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5500488499961205,
RN2012_L13,0.5572106371123057,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5579624457500023,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5522618778884373,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5746072853509663,
HH2022_Reporter intensity 6,0.5580677110689339,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5679289960306505,0.38708335021585555
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5566842352151684,0.37404755138298307
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5438965028590709,
KBE2022_Log2_Ex_19_U,0.5614197994872929,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,0.5590672624495847,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5622306021973295,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.572698234684678,0.4117645586202932
HH2022_Reporter intensity 1,0.5615286496118427,
HH2022_Reporter intensity 2,0.5612729436386068,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5562717538430274,0.4348236393886502
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5469531131923753,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5657812766913726,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5597303144380537,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5650505308236563,
KBE2022_Log2_Ex_9_U,0.5657121448348136,
AH2018_SILAC_M_3_N,0.5600996622751703,
KBE2022_Log2_Ex_13_T,0.5639576626779339,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,0.39907432039949436
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5583359032158666,
RN2012_L12,0.5536959671651105,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5598855518126096,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5539419252355726,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5463825566516334,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5595307357973903,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5594495139969531,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5611742786747136,
CK2022_5 200-1,0.5614984345182471,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5673097034806129,
AH2018_SILAC_MR_1_X,,0.45276591093958934
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5635817503488587,
AH2018_SILAC_3_C,0.5598920782404185,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.548070944440763,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5607434553852013,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5604449410130452,0.4682102555788931
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.554515864812723,0.43149237416998076
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5642168667376106,
AH2018_SILAC_IT_2_N,0.5617983740638155,
AH2018_SILAC_IT_1_X,0.5626122187801139,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.5677159296572872,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.561984086401933,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5664234568488694,0.38656729616823576
RN2012_H06,0.5523834482812012,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5602675482854745,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5584356592609592,
WZ2023_Su_025_10min,0.5620321293811527,
AH2018_LFQ_IT_4_X,0.5601347574495045,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5529579938679143,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5698919355056169,0.46289473201297904
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5408019328012859,0.41547672356752
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5682800398814065,0.42792865380314676
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5529893449216381,0.41281278335756166
LY2019_P7+,0.5553502766306943,
EP2017_Untreated R#1 normalized log2 ratio,0.5335152108117588,0.42078682399752204
RN2012_L10,0.5549476991782745,
PG2020_Intensity 4h_C,0.5569215293730345,0.41421466598283985
EP2017_Mitotic R#3 normalized log2 ratio,0.5818237554247361,0.43170203059754725
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5591606272449551,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5628203069071241,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5575295296276257,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5467392499989118,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5636499104236619,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5818509558990883,0.43336513640560587
GF2025_P9_Sph,,
CK2022_6 200-1,0.5611183990296293,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5492227449247327,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,0.56875610119368,0.43411997945959174
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.561365692400952,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5549672281067256,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5480163290306698,0.4156421004479421
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5647878160789634,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.564382982893979,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.4237038595553204
PG2020_Intensity CT_C,0.5555022775642028,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5646087470602554,
EP2017_Untreated R#3 log2 ratio,0.5728627416584255,0.4367335193182004
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5568917919947001,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5572107474323049,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5545132655301764,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5551070305779644,0.4399592466195183
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5633056616551726,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5636515228458282,
CK2022_2 16-1,0.5483497417757878,
RAM2015_Log2 B,0.5626005845125738,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.555322396721156,
WZ2023_Su_025_30min,0.558207900573613,
AH2018_LFQ_4_N,0.5623707277805333,
CR2017_Ratio Replicate 1.2,0.5649805235106417,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5565171503126871,
AH2018_SILAC_M_1_X,0.5574563499866733,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5482140543757945,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5619045852841517,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5546472884215987,0.4534378414739031
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5570095403671691,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5514819678291824,
AH2018_LFQ_2_X,0.5582657474011908,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5543319638057636,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5554754792370108,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5616413488305464,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5502935263323847,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5432115619578608,
AH2018_LFQ_3_N,0.5678226042638544,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5557449779011183,0.46620701418809296
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5612837549357879,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5535568101705279,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5549036100610506,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5532189383627112,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5737413045248364,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5558805746844816,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5509702708053471,
PG2020_Intensity 10h_D,0.5477356379182852,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5517026187717536,0.4189820786388791
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,0.5637437997607563,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5523943971435976,
CK2022_6 40-1,0.5539693488531484,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5605612271987552,
LY2019_P3-,0.5429613876545312,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5687848606094409,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.5586375206482377,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5585142710097718,0.4269627960801296
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5635661859707894,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5616313477792106,0.37158386965686346
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5653729916424292,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5569119663635682,
LY2019_P8+,0.566052538282647,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5619765443365102,0.4262981805299801
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5644389750671728,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.39415923615095266
LY2019_P2-,,
AH2018_LFQ_IT_1_X,0.5570723493932438,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5661958608609261,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5548208061481645,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5601725844167588,
AH2018_TMTMS3_3_N,0.5664132683769668,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.45266158631222897
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5824979693115324,0.4324060250811046
KBE2022_Log2_Ex_36_T,0.5609065929641373,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5625008830781809,
KS2014_Intensity C2,0.5562958306170782,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5629051484435282,
CK2022_9 200-1,0.5620260712323543,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5616364621283048,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5531582756357487,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5540968263143402,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5649760594011083,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5366527185376689,0.42304058263528144
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5574842583967236,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.569182838621143,0.43666765553700376
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5533048184855182,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.44633766987334483
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5476696920798199,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.557309916390108,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5673912201808595,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5591366595037768,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5658744606380707,
KBE2022_Log2_Ex_29_U,0.5635936637326657,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5625872182918263,
AH2018_LFQ_IT_4_N,0.5600271650571921,
CK2022_15 200-1,0.5631803179136652,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5602942498228627,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5526216904167387,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5616164404378466,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5561808544877136,
RN2012_H01,0.5555818337476635,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.53968838458754,0.4146828502276376
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5638241415104752,
WZ2023_Pe_010_20min,0.5662797668768486,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5567981981224134,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.5599665683143932,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5656562285511771,
AH2018_SILAC_M_2_X,0.5658105447298307,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5589940433402564,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5560407223155333,
PG2020_Intensity 6h_C,0.5299618824827904,0.42542240602907017
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5705796167756328,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5657240584765594,0.37711841831225085
CK2022_15 16-1,0.5499707896301603,
CK2022_3 16-1,0.5476528057631906,
LY2019_P4-,0.5695723689504193,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,0.5430183896381444,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5816682114112224,0.4334915705255529
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.4129411313036659
AR2021_L41 10 μM,0.5653148848567713,
CF2017_EOC 2,,0.4159064536057615
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5570563088109936,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5475405523564869,
ZX2022_CB treated Replicate 1,0.55771545337268,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5618300008363413,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5583640576025282,0.39028603201635503
AR2021_L41 1 μM,0.558111827126235,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5571527480034278,0.37439117298924834
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5592183061052434,
KS2014_Intensity C4,0.5509687094217626,0.41426092828095445
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5627957376286105,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.563389719976992,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5535196987168185,
WZ2023_Pu_025_10min,0.5680158884899092,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.4091527081014437
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5645572653569153,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5653172903965231,
KS2014_Intensity C6,0.5472308096953266,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5534601569696643,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5606432771356074,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5559954970209432,
AH2018_SILAC_IT_2_C,0.5536706151726688,
CK2022_5 40-1,0.5541815378316238,
AH2018_LFQ_3_X,0.5616939657691942,
UK2020_UA_3,,
LY2019_P7-,0.5615211035745835,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5540270383238917,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5426344295854413,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5463527914207753,
PG2020_Intensity CT_B,0.5585354940843676,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.440780422045707
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5619627971786603,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5630041760778952,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.562225345018905,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5517370192581655,
AST2020_anti-CD3+PDL2,0.5589712837060599,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5585381955537347,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5832749913795632,0.4327670931011391
AH2018_TMTMS2_1_X,0.5577868960118229,0.391018347713559
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.414140589201371
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5570604557474927,
PG2020_Intensity 10h_B,0.5458091996420391,
AH2018_TMTMS3_1_X,0.5541997720908608,
CF2017_FTE 14,,0.41316453431234873
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5475984465050452,0.4031802363645409
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5609532841799982,
EP2017_Untreated R#2 normalized log2 ratio,0.5524859720347826,0.4321198990585713
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.552747731507955,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.549446191022045,0.4166765160532841
AS2011_Ratio H/L Normalized RNAi_2_1,,
